TY - JOUR
T1 - Independent evolution of multi-dominant viral genome species observed in a hepatitis C virus carrier
AU - Ando, Tomomi
AU - Aizaki, Hideki
AU - Sugiyama, Masaya
AU - Date, Tomoko
AU - Hayashi, Kazuhiko
AU - Ishigami, Masatoshi
AU - Katano, Yoshiaki
AU - Goto, Hidemi
AU - Mizokami, Masashi
AU - Muramatsu, Masamichi
AU - Kuroda, Makoto
AU - Wakita, Takaji
N1 - Funding Information:
This study was partially supported by The Japan Society for the Promotion of Science KAKENHI (No. JP207K08369) and The Japan Agency for Medical Research and Development, AMED (Nos. JP21fk02100539j0103, 21fk0310103j0305 and 21fk0210065j1002). HG received a research grant from AstraZeneca, Astellas Pharma, Ajinomoto Pharmaceutical Co, Bristol-Myers Squibb, Chugai Pharmaceutical Co, Daiichi Sankyo, Dainippon Sumitomo Pharma, Eisai, Mitsubishi Tanabe Pharma, MSD, Otsuka Pharmaceutical Co and Takeda Pharmaceutical Co. KH received a research grant from AstraZeneca, Eisai, and MSD.Hidemi Goto reports a relationship with AstraZeneca, Astellas Pharma, Ajinomoto Pharmaceutical Co, Bristol-Myers Squibb, Chugai Pharmaceutical Co, Daiichi Sankyo, Dainippon Sumitomo Pharma, Eisai, Mitsubishi Tanabe Pharma, MSD, Otsuka Pharmaceutical Co and Takeda Pharmaceutical Co that includes: funding grants. Kazuhiko Hayashi reports a relationship with AstraZeneca, Eisai, and MSD that includes: funding grants.
Funding Information:
This study was partially supported by The Japan Society for the Promotion of Science KAKENHI (No. JP207K08369 ) and The Japan Agency for Medical Research and Development, AMED (Nos. JP21fk02100539j0103 , 21fk0310103j0305 and 21fk0210065j1002 ). HG received a research grant from AstraZeneca, Astellas Pharma, Ajinomoto Pharmaceutical Co , Bristol-Myers Squibb, Chugai Pharmaceutical Co , Daiichi Sankyo, Dainippon Sumitomo Pharma , Eisai, Mitsubishi Tanabe Pharma , MSD, Otsuka Pharmaceutical Co and Takeda Pharmaceutical Co . KH received a research grant from AstraZeneca, Eisai, and MSD.
Publisher Copyright:
© 2022
PY - 2022/12
Y1 - 2022/12
N2 - The viral genome quasispecies composition of hepatitis C virus (HCV) could have important implications to viral pathogenesis and resistance to anti-viral treatment. The purpose of the present study was to profile the HCV RNA quasispecies. We developed a strategy to determine the full-length HCV genome sequences co-existing within a single patient serum by using next-generation sequencing technologies. The isolated viral clones were divided into the groups that can be distinguished by core amino acid 70 substitution. Subsequently, we determined HCV full-length genome sequences of three independent dominant species co-existing in the sequential serum with a 7-year interval. From phylogenetic analysis, these dominant species evolved independently. Our study demonstrated that multiple dominant species co-existed in patient sera and evolved independently.
AB - The viral genome quasispecies composition of hepatitis C virus (HCV) could have important implications to viral pathogenesis and resistance to anti-viral treatment. The purpose of the present study was to profile the HCV RNA quasispecies. We developed a strategy to determine the full-length HCV genome sequences co-existing within a single patient serum by using next-generation sequencing technologies. The isolated viral clones were divided into the groups that can be distinguished by core amino acid 70 substitution. Subsequently, we determined HCV full-length genome sequences of three independent dominant species co-existing in the sequential serum with a 7-year interval. From phylogenetic analysis, these dominant species evolved independently. Our study demonstrated that multiple dominant species co-existed in patient sera and evolved independently.
UR - http://www.scopus.com/inward/record.url?scp=85136722353&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136722353&partnerID=8YFLogxK
U2 - 10.1016/j.bbrep.2022.101327
DO - 10.1016/j.bbrep.2022.101327
M3 - Article
AN - SCOPUS:85136722353
SN - 2405-5808
VL - 32
JO - Biochemistry and Biophysics Reports
JF - Biochemistry and Biophysics Reports
M1 - 101327
ER -